Zobrazeno 1 - 7
of 7
pro vyhledávání: '"José L. López‐Lorenzo"'
Autor:
Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro, Pilar Llamas, José L. López-Lorenzo, Javier Cornago, Javier Santos, José Fernández-Piqueras, María Villa-Morales
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-13 (2024)
Abstract Precursor T-cell neoplasms (T-ALL/LBL) are aggressive hematological malignancies that arise from the malignant transformation of immature thymocytes. Despite the JAK/STAT pathway is recurrently altered in these neoplasms, there are not pharm
Externí odkaz:
https://doaj.org/article/c8037d4ae28942409f7da1cc7c6cb1b9
Autor:
Tamara Castaño-Bonilla, Raquel Mata, Daniel Láinez-González, Raquel Gonzalo, Susana Castañón, Francisco Javier Díaz de la Pinta, Carlos Blas, José L. López-Lorenzo, Juan Manuel Alonso-Domínguez
Publikováno v:
Medicina, Vol 60, Iss 5, p 807 (2024)
Spontaneous remissions (SRs) in blastic plasmacytoid dendritic cell neoplasms (BPDCNs) are infrequent, poorly documented, and transient. We report a 40-year-old man presenting with bycitopenia and soft tissue infection. The bone marrow exhibited 3% a
Externí odkaz:
https://doaj.org/article/05ab7fb97182490e9a5354ab4d81268d
Autor:
Edwin U. Suárez, Javier Cornago, Miguel Á. Piris, Socorro M. Rodriguez Pinilla, José L. López‐Lorenzo, Carlos Soto
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 560-562 (2022)
Externí odkaz:
https://doaj.org/article/b9a7843b171349cba67d4c88b697f885
Autor:
Antonio Lahera, Pilar López‐Nieva, Hernán Alarcón, José L. Marín‐Rubio, María Á. Cobos‐Fernández, Pablo Fernández‐Navarro, Agustín F. Fernández, Laura Vela‐Martín, Isabel Sastre, Sara Ruiz‐García, Pilar Llamas, José L. López‐Lorenzo, Javier Cornago, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales
Publikováno v:
Scopus
Despite the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway being frequently altered in T-ALL/LBL, no specific therapy has been approved for T-ALL/LBL patients with constitutive signalling by JAK/STAT, so there is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f71d0f2b00cba28da6de3f3d19757bf6
https://doi.org/10.1111/bjh.18694
https://doi.org/10.1111/bjh.18694
Autor:
Marta López-Nevado, Javier Ortiz-Martín, Cristina Serrano, María A. Pérez-Saez, José L. López-Lorenzo, Francisco J. Gil-Etayo, Edgar Rodríguez-Frías, Oscar Cabrera-Marante, Pablo Morales-Pérez, María S. Rodríguez-Pinilla, Rebeca Manso, Rocío N. Salgado-Sánchez, Ana Cerdá-Montagud, Juan F. Quesada-Espinosa, María J. Gómez-Rodríguez, Estela Paz-Artal, Cecilia Muñoz-Calleja, Reyes Arranz-Sáez, Luis M. Allende
Publikováno v:
Journal of Clinical Immunology. 43:165-180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::650a3e90b80a8ce813177c7aba97347d
https://doi.org/10.1007/s10875-022-01361-y
https://doi.org/10.1007/s10875-022-01361-y
Autor:
Tamara Castaño-Bonilla, Juan M. Alonso-Dominguez, Eva Barragán, Rebeca Rodríguez-Veiga, Claudia Sargas, Cristina Gil, Carmen Chillón, María B. Vidriales, Raimundo García, Joaquín Martínez-López, Rosa Ayala, María J. Larrayoz, Eduardo Anguita, Rebeca Cuello, Alberto Cantalapiedra, Estrella Carrillo, Elena Soria-Saldise, Jorge Labrador, Isabel Recio, Lorenzo Algarra, Carlos Rodríguez-Medina, Cristina Bilbao-Syeiro, Juan A. López-López, Josefina Serrano, Erik De Cabo, María J. Sayas, María T. Olave, Joaquín Sánchez-García, Mamen Mateos, Carlos Blas, Jose L. López-Lorenzo, Daniel Lainez-Gonzalez, Juana Serrano, David Martínez-Cuadrón, Miguel A. Sanz, Pau Montesinos
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract FLT3-ITD mutations are detected in approximately 25% of newly diagnosed adult acute myeloid leukemia (AML) patients and confer an adverse prognosis. The FLT3-ITD allelic ratio has clear prognostic value. Nevertheless, there are numerous manu
Externí odkaz:
https://doaj.org/article/fdbb40702f114bf78acc458a1b88a71c
Autor:
Sara Fañanas-Baquero, Oscar Quintana-Bustamante, Daniel P. Dever, Omaira Alberquilla, Rebeca Sanchez-Dominguez, Joab Camarena, Isabel Ojeda-Perez, Mercedes Dessy-Rodriguez, Rolf Turk, Mollie S. Schubert, Annalisa Lattanzi, Liwen Xu, Jose L. Lopez-Lorenzo, Paola Bianchi, Juan A. Bueren, Mark A. Behlke, Matthew Porteus, Jose-Carlos Segovia
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss , Pp 237-248 (2021)
Pyruvate kinase deficiency (PKD), an autosomal-recessive disorder, is the main cause of chronic non-spherocytic hemolytic anemia. PKD is caused by mutations in the pyruvate kinase, liver and red blood cell (PKLR) gene, which encodes for the erythroid
Externí odkaz:
https://doaj.org/article/36126901876d48f9918fa4a741965bd8